These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17391135)

  • 1. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.
    Venick RS; McDiarmid SV; Farmer DG; Gornbein J; Martin MG; Vargas JH; Ament ME; Busuttil RW
    Am J Transplant; 2007 Apr; 7(4):955-63. PubMed ID: 17391135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
    Miyagawa-Hayashino A; Haga H; Egawa H; Hayashino Y; Sakurai T; Minamiguchi S; Tanaka K; Manabe T
    Transplantation; 2004 Jul; 78(1):128-35. PubMed ID: 15257051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.
    Avitzur Y; Ngan BY; Lao M; Fecteau A; Ng VL
    J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):222-7. PubMed ID: 17667719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent and De Novo Autoimmune Hepatitis.
    Stirnimann G; Ebadi M; Czaja AJ; Montano-Loza AJ
    Liver Transpl; 2019 Jan; 25(1):152-166. PubMed ID: 30375180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
    Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
    Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
    Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic surveillance after liver transplantation due to autoimmune hepatitis.
    Puustinen L; Boyd S; Arkkila P; Isoniemi H; Arola J; Färkkilä M
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo autoimmune hepatitis -is this different in adults compared to children?
    Kerkar N; Vergani D
    J Autoimmun; 2018 Dec; 95():26-33. PubMed ID: 30396746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
    Andries S; Casamayou L; Sempoux C; Burlet M; Reding R; Bernard Otte J; Buts JP; Sokal E
    Transplantation; 2001 Jul; 72(2):267-72. PubMed ID: 11477351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo autoimmune hepatitis after liver transplantation.
    Guido M; Burra P
    Semin Liver Dis; 2011 Feb; 31(1):71-81. PubMed ID: 21344352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
    Liberal R; Vergani D; Mieli-Vergani G
    Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience.
    Cho JM; Kim KM; Oh SH; Lee YJ; Rhee KW; Yu E
    Transplant Proc; 2011; 43(6):2394-6. PubMed ID: 21839275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cellular rejection in paediatric liver transplantation: aetiology and outcome.
    D'Antiga L; Dhawan A; Portmann B; Francavilla R; Rela M; Heaton N; Mieli-Vergani G
    Transplantation; 2002 Jan; 73(1):80-4. PubMed ID: 11792983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Hepatitis in the Liver Transplant Graft.
    Beal EW; Black SM; Michaels A
    Clin Liver Dis; 2017 May; 21(2):381-401. PubMed ID: 28364820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Autoimmune Hepatitis Following Liver Transplantation.
    Kwon JH; Hanouneh IA; Allende D; Yerian L; Diago T; Eghtesad B; Zein NN
    Transplant Proc; 2018 Jun; 50(5):1451-1456. PubMed ID: 29880369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to steroids in de novo autoimmune hepatitis after liver transplantation.
    Salcedo M; Vaquero J; Bañares R; Rodríguez-Mahou M; Alvarez E; Vicario JL; Hernández-Albújar A; Tíscar JL; Rincón D; Alonso S; De Diego A; Clemente G
    Hepatology; 2002 Feb; 35(2):349-56. PubMed ID: 11826408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.